
News|Articles|December 1, 2007
First-time generic approvals, December 2007
First-time generic approvals: rivastigmine capsules
Advertisement
Key Points
Rivastigmine capsules, 1.5, 3, 4.5, and 6 mg base (equiv to Exelon capsules)
SUN
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
2
Real-World Usage of Biologics in Psoriatic Arthritis
3
Researchers discover new pathway to fight liver inflammation
4
Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
5





















